🔎 Trials Near Me

Akèy › Gliyòm › Minnesota › Rochester

Etid klinik pou Gliyòm nan Rochester, MN

9 etid pou Gliyòm ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease

Ap rekriteFaz 1 bonè
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07025226

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

Ap rekrite
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT04047264

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial

Ap rekrite
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07074756

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Ap rekriteFaz 1/2
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT07468136

Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab

Ap rekriteFaz 1/2
  • Mayo Clinic, Rochester
Laj 19 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT06011109

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Ap rekriteFaz 1/2
  • Mayo Clinic Cancer Center, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06810544

Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.

Ap rekriteFaz 1
  • Mayo Clinic in Rochester, Rochester
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06482905

Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma

Ap rekriteFaz 1 bonè
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Nov 4, 2025 · NCT05717153

Etid Gliyòm nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.